| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 65 |
| 1 | NATALIZUMAB | 23 |
| 2 | ALENDRONATE SODIUM | 7 |
| 3 | INTERFERON BETA-1A | 7 |
| 4 | TERIPARATIDE | 6 |
| 5 | GABAPENTIN | 5 |
| 6 | INSULIN GLARGINE | 5 |
| 7 | METHOTREXATE | 5 |
| 8 | METHOTREXATE SODIUM | 5 |
| 9 | SIMVASTATIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 1 | 0.0011 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 2 | NIZATIDINE | 1 | 0.0007 |
| 3 | IDURSULFASE | 2 | 0.0005 |
| 4 | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | 1 | 0.0004 |
| 5 | LEVONORGESTREL | 65 | 0.0003 |
| 6 | BACLOFEN INJECTION | 1 | 0.0003 |
| 7 | CALCITONIN SALMON | 1 | 0.0003 |
| 8 | GARLIC | 1 | 0.0002 |
| 9 | REGADENOSON | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 66 |
| 1 | Progestin-containing Intrauterine System [EPC] | 65 |
| 2 | Integrin Receptor Antagonist [EPC] | 23 |
| 3 | Interferon beta [EPC] | 7 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 5 | Benzodiazepine [EPC] | 6 |
| 6 | Corticosteroid [EPC] | 6 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 6 |
| 8 | Parathyroid Hormone Analog [EPC] | 6 |
| 9 | Vitamin C [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 1 | 0.0003 |
| 1 | Integrin Receptor Antagonist [EPC] | 23 | 0.0003 |
| 2 | Progestin [EPC] | 66 | 0.0002 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |
| 4 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 7 | Parathyroid Hormone Analog [EPC] | 6 | 0.0001 |
| 8 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 9 | Antiarrhythmic [EPC] | 4 | 0.0000 |